5 Stocks to Buy With Extensive Robotics Applications for 2026
π€ Robotics companies are driving efficiency in manufacturing, healthcare, and logistics, with the global market poised for significant growth fueled by AI and automation.
β οΈ Investors face risks in the robotics space, including high R&D costs, regulatory challenges, data privacy concerns, and societal impacts of automation.
π Zacks Investment Research recommends five robotics stocks with a "Buy" (Rank #2) rating for investment through 2026.
π» Autodesk (ADSK) benefits from a cloud subscription model, strong cash flow, and AI-driven innovation across AutoCAD, Revit, and Fusion platforms.
π Autodesk is expected to grow revenue by 13% and earnings by 18.7% for the current year ending January 2027.
π₯ Intuitive Surgical (ISRG) is embedding AI into its robotic ecosystem via Case Insights, which provides objective performance metrics for surgeons.
π ISRG is piloting telecollaboration through Intuitive Telepresence to support remote surgical education and scaling digital features in healthcare.
π Intuitive Surgical expects revenue growth of 16.2% and earnings growth of 15.7% for the current year with improved analyst estimates.
π Rockwell Automation (ROK) is focusing on productivity through automation investments across life sciences, food & beverage, mining, and other end markets.
π Recent acquisitions and portfolio optimizations at Rockwell are expected to drive growth despite manufacturing contraction and cost headwinds.
βοΈ Rockwell Automation anticipates revenue growth of 6% and earnings growth of 15.3% for the year ending September 2026.
π¬ Nordson (NDSN) is benefiting from steady demand in medical components and engineered fluid solutions, particularly in semiconductor electronics dispense.
π The Industrial Precision Solutions segment at Nordson has returned to modest organic growth as automotive and polymer processing demand stabilizes.
- Intuitive Surgical is embedding AI and digital tools into its robotic ecosystem, with Case Insights integrated into da Vinci 5 providing objective performance indicators that link to improved clinical outcomes like reduced hospital stays.
- ISRG is piloting Intuitive Telepresence for remote surgical support and education, positioning itself as a leader in broader AI-driven healthcare transformation.
- The Zacks Consensus Estimate for ISRG's current year earnings has improved by 3.7% over the last seven days, signaling growing analyst confidence.
- ISRG is expected to post revenue and earnings growth rates of 16.2% and 15.7%, respectively, for the current year.
- Rockwell Automation is benefiting from investments across many end markets that will support growth despite cost headwinds, supply-chain issues, and a challenging contraction in manufacturing activity.
- ROK's optimization efforts and price increase actions are expected to drive growth and negate negative market factors, while recent acquisitions will further boost performance.
- Rockwell Automation is expected to deliver an earnings growth rate of 15.3% for the current year ending September 2026.
- Nordson is seeing steady demand in medical components, with its Advanced Technology Solutions segment being lifted by strength in semiconductor-related electronics dispense and x-ray system product lines.
- The article explicitly warns that robotics technology is still evolving, posing inherent risks of high R&D costs with no guaranteed success.
- Broader industry risks mentioned include regulatory challenges, market volatility, concerns about job displacement, and data privacy issues.
- Intuitive Surgical's new AI features like Case Insights and Telepresence represent early-stage pilots that face potential delays or require additional regulatory adjustments before full commercial scaling.
- Rockwell Automation must successfully navigate headwinds from elevated costs and a challenging contraction in manufacturing activity to realize its growth targets.
- The article notes that only 0.1% of Rockwell Automation's earnings estimate improved over the last 30 days, suggesting relatively weak analyst momentum compared to peers.
- Nordson's recent business performance is described as merely returning to 'modest organic growth,' implying a lack of significant upside momentum in key segments.